Consistent with this, in some tumor types, including head and neck squamous cell carcinoma and esophageal cancer, a higher density of CD163-positive TAMs is closely correlated to worse clinical courses, whereas no significant association is seen between the density of CD68-positive TAMs and clinical prognosis [36, 37]. Here, CD163 is linked to head and neck squamous cell carcinoma.